News / Korea / yonhap_finance
Yuhan Corp. Secures 131.1 Billion Won API Supply Deal with Global Pharma
Health Technology · Pharmaceuticals: Major · yonhap_finance · 2026-09-01
000100
Yuhan Corp. has signed a 131.1 billion won contract to supply active pharmaceutical ingredients to an undisclosed global pharmaceutical company through 2028.
What Happened
Contract Details: Yuhan Corp. announced on the 1st that it has entered into a supply agreement for active pharmaceutical ingredients (API) worth 131.1 billion won with a global pharmaceutical firm. This deal represents approximately 6% of the company's consolidated revenue of 2.1866 trillion won reported last year.
Duration: The term of the supply agreement spans from the date of the announcement until May 31, 2028. Both parties have noted that the contract period and specific terms remain subject to change based on mutual agreement.
Confidentiality: The company has opted not to disclose the identity of the global pharmaceutical partner, citing business confidentiality requirements. Consequently, the name of the counterparty remains undisclosed to the public.
Strategic Impact: This significant supply contract underscores Yuhan's competitive standing in the global API market. By securing long-term supply commitments, the company is expected to bolster its revenue stability and growth trajectory over the coming years.